Skip to main content

Table 3 Survival status of the groups

From: Levosimendan may improve survival in patients requiring mechanical assist devices for post-cardiotomy heart failure

  Conventional Levosimendan P value
n 29 9  
AD survival 20 9 p = 0.082
ICU survival 9 8 p = 0.005
Hosp survival 7 8 p = 0.001
180-day survival 3 7 p < 0.001
  1. Chi square test was used and p values between the groups were determined according to exact Fischer's test. 180-day survival, survival of the first 180 days after surgery; AD survival, survival of assist device; Hosp survival, survival of hospital stay; ICU survival, survival of intensive care unit stay.